Product class: Authorized package
Medicinal product class: Veterinary medicine
Package code: 1814150
Name of medicinal product: Butasal-100
Active substances:
Butafosfan+Cyanocobalamin
Estonian, English, Latin
ATC code: QA12CX92
Dosage form: solution for injection
Route of administration: intramuscular use; subcutaneous use; intravenous use
Strengh: 100mg+0,05mg 1ml
Amount in package: 100ml 6TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: As supportive treatment of metabolic or reproductive disorders. In case of peri-parturient metabolic disorders, tetany and paresis (milk fever), the product should be administered in addition to magnesium and calcium, respectively.
Safety features: No
Summary of product characteristics (SPC):  (last updated 07 May 2021)
Package information leaflet (PIL): EST  (last updated 07 May 2021)
Labelling:  (last updated 07 May 2021)
Withdrawal time: Veis, hobune Lihale ja söödavatele kudedele: 0 päeva. Piimale: 0 tundi.
Species: hobune, koer, veis, kass
Last imported to Estonia: 31 March 2022
Marketing authorization holder: Interchemie Werken De Adelaar Eesti aktsiaselts 
Marketing authorization number: 2233 
Marketing authorization issued on: 05 May 2020 
Marketing authorization expires on: 05 May 2025 
Marketing authorization procedure type: Mutual recognition 
Entry/Changing date: 21 January 2022
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription